PharmaTher Receives FDA Approval for Phase 2 Clinical Trial on ... - Best Stocks
| PHRRF Stock | USD 0.17 0.01 5.56% |
Roughly 62% of Pharmather Holdings' investor base is looking to short. The analysis of current outlook of investing in Pharmather Holdings suggests that many traders are alarmed regarding Pharmather Holdings' prospects. The current market sentiment, together with Pharmather Holdings' historical and current headlines, can help investors time the market. In addition, many technical investors use Pharmather Holdings stock news signals to limit their universe of possible portfolio assets.
Pharmather Holdings otc stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Pharmather daily returns and investor perception about the current price of Pharmather Holdings as well as its diversification or hedging effects on your existing portfolios.
Pharmather |
PharmaTher Receives FDA Approval for Phase 2 Clinical Trial on ... Best Stocks
Read at news.google.com
 |
Pharmather Holdings Fundamental Analysis
We analyze Pharmather Holdings' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pharmather Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pharmather Holdings based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Earning
Price To Earning Comparative Analysis
Pharmather Holdings is currently under evaluation in price to earning category among its peers. Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Pharmather Holdings Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pharmather Holdings otc stock to make a market-neutral strategy. Peer analysis of Pharmather Holdings could also be used in its relative valuation, which is a method of valuing Pharmather Holdings by comparing valuation metrics with similar companies.
Peers
Pharmather Holdings Related Equities
| FBIO | Fortress Biotech | 7.98 | ||||
| ADIL | Adial Pharmaceuticals | 7.00 | ||||
| ADTX | Aditxt | 5.71 | ||||
| LUMO | Lumos Pharma | 1.86 | ||||
| XOMAO | XOMA | 0.39 | ||||
| CKPT | Checkpoint Therapeutics | 1.82 | ||||
| GHRS | GH Research | 2.80 | ||||
| RVPH | Reviva Pharmaceuticals | 3.23 | ||||
| ATXI | Avenue Therapeutics | 9.77 | ||||
| RNAZ | Transcode Therapeutics | 20.00 |
Complementary Tools for Pharmather OTC Stock analysis
When running Pharmather Holdings' price analysis, check to measure Pharmather Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmather Holdings is operating at the current time. Most of Pharmather Holdings' value examination focuses on studying past and present price action to predict the probability of Pharmather Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmather Holdings' price. Additionally, you may evaluate how the addition of Pharmather Holdings to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |